AlphaCrest Capital Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,989
| Closed | -$334K | – | 1041 |
|
|
2022
Q3 | $334K | Sell |
6,989
-5,351
| -43% | -$256K | 0.02% | 1117 |
|
|
2022
Q2 | $730K | Sell |
12,340
-1,811
| -13% | -$107K | 0.04% | 809 |
|
|
2022
Q1 | $1.65M | Buy |
14,151
+7,030
| +99% | +$818K | 0.09% | 317 |
|
|
2021
Q4 | $1.07M | Sell |
7,121
-5,039
| -41% | -$759K | 0.04% | 758 |
|
|
2021
Q3 | $1.45M | Sell |
12,160
-296
| -2% | -$35.3K | 0.08% | 440 |
|
|
2021
Q2 | $1.21M | Buy |
12,456
+2,256
| +22% | +$220K | 0.05% | 570 |
|
|
2021
Q1 | $900K | Buy |
10,200
+6,158
| +152% | +$543K | 0.05% | 540 |
|
|
2020
Q4 | $387K | Sell |
4,042
-2,776
| -41% | -$266K | 0.03% | 796 |
|
|
2020
Q3 | $774K | Buy |
+6,818
| New | +$774K | 0.08% | 365 |
|
|
2020
Q2 | – | Sell |
-11,100
| Closed | -$714K | – | 1119 |
|
|
2020
Q1 | $714K | Buy |
11,100
+6,800
| +158% | +$437K | 0.09% | 415 |
|
|
2019
Q4 | $256K | Sell |
4,300
-5,800
| -57% | -$345K | 0.02% | 1137 |
|
|
2019
Q3 | $596K | Buy |
+10,100
| New | +$596K | 0.04% | 828 |
|